Home | Publications | Treatments | Skin care place holder
place holder place holder

Skin care


Medicated Skin Care in the Philippines


Publication Date   January 2008
Publisher   Euromonitor International
Product Type   Strategic Report
Pages   28
ISBN Number   not applicable
Product Code   EUR859
Ask a question about this product?

Price £450.00

approximately: $903 | €565

Summary


Euromonitor International's Medicated Skin Care in Philippines report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - Mexico

OTC Healthcare in Mexico : Market Insight

EXECUTIVE SUMMARY
Pharmaceutical players struggle to maintain share Success is based on lobbying doctors Socio-economic trends favour OTC healthcare over the forecast period KEY TRENDS AND DEVELOPMENTS
Seguro Popular promises health coverage for the neglected Generics face an uphill battle Farmacias Similares remains strong Socio-economic trends favour OTC healthcare OTC sales expand along with retail growth MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins and dietary supplements registration and classification Generics Consumer expenditure on health goods and medical services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - Mexico

Bayer de Mxico SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 2 Bayer de Mxico SA de CV: Key Facts
Summary 3 Bayer de Mxico SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 4 Bayer de Mxico SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 5 Bayer de Mxico SA de CV: Competitive Position 2006
Boehringer Ingelheim Promeco SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 6 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 7 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2006
GlaxoSmithKline Mxico SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 9 GlaxoSmithKline Mxico SA de CV: Key Facts
Summary 10 GlaxoSmithKline Mxico SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 11 Summary GlaxoSmithKline Mxico SA de CV: Competitive Position 2006
Laboratorios Liomont SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 12 Laboratorios Liomont SA de CV: Key Facts
Summary 13 Laboratorios Liomont SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 14 Laboratorios Liomont SA de CV: Production Statistics 2006
Summary 15 Laboratorios Liomont SA de CV: Production Capacity by Format
COMPETITIVE POSITIONING
Summary 16 Summary Laboratorios Liomont SA de CV: Competitive Position 2006
Merck-Mxico SA - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 17 Merck-Mxico SA: Key Facts
Summary 18 Merck-Mxico SA: Operational Indicators
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 19 Merck-Mxico SA: Competitive Position 2006
Novartis Farmacutica SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 20 Novartis Farmacutica SA de CV: Key Facts
Summary 21 Novartis Farmacutica SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 22 Novartis Farmacutica SA de CV: Competitive Position 2006
Pfizer SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 23 Pfizer SA de CV: Key Facts
Summary 24 Pfizer SA de CV: Operational Indicators
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 25 Pfizer SA de CV: Competitive Position 2006
Procter & Gamble de Mxico SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 26 Procter & Gamble de Mxico SA de CV Key Facts
Summary 27 Procter & Gamble de Mxico SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 28 Procter & Gamble de Mxico SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 29 Procter & Gamble de Mxico SA de CV: Competitive Position 2006
Wyeth SA de CV - OTC Healthcare - Mexico
STRATEGIC DIRECTION KEY FACTS
Summary 30 Wyeth SA de CV: Key Facts
Summary 31 Wyeth SA de CV: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 32 Wyeth SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 33 Wyeth SA de CV: Competitive Position 2006

Cough, cold and allergy (hay fever) remedies in Mexico

HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 14 Sales of Decongestants by Type: Value 2001-2006
Table 15 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011